I am a Senior Lecturer in Molecular Dermatology leading a research team at St. John's Institute of Dermatology, King's College London. Since 2024, I have been a Fellow of the Higher Education Academy (FHEA) and contribute regularly to teaching and education in the university. My research career began with a PhD in Molecular Dermatology from the Albert-Ludwig University in Freiburg, Germany. Following postdoctoral fellowships at the Imagine Institute in Paris and Columbia University in New York, I joined King's College London in 2020 as a tenured faculty member. My research focuses on developing novel treatment strategies for inherited diseases and skin cancer.

My expertise encompasses molecular biology, biochemistry, and developmental biology. My laboratory combines gene editing technologies and lipid nanoparticles to develop treatments that repair causal genetic defects in monogenic diseases, including recessive dystrophic epidermolysis bullosa (RDEB), which is an inherited skin fragility disorder strongly associated with the development of fatal skin cancers. We also employ 3D in vitro models, such as spheroids, to better understand the immunopathogenesis of skin cancer in RDEB.